Back

US-Rx Care urges contract tests as drug costs forecast to rise 12% in 2026

Verifying
  • US-Rx Care urges employers to test PBM contracts for fiduciary and financial obligations.
  • Drug costs are estimated to rise 12% in 2026, versus 8.5% for total healthcare costs.
  • Nautilus Contract X-Ray rated one contract fail or concern on all 10 measures.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.